The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Normetol     3-(2-amino-1-hydroxy- ethyl)phenol

Synonyms: Norenol, Metacardiol, Norfenefrina, Norfenefrine, Norfenefrinum, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Zondel

  • The NMH group received norfenefrine-masked hypovolemia but no endotoxin [1].
  • Norfenefrine-masked hypovolemia caused disseminated cardiac cell necrosis independent of endotoxemia (p < .05 vs. ENDO) [1].
  • As we could show in restrained animals, where DL-octopamine was applied topically onto the undesheated mesothoracic ganglion, the complete suppression of the resistance reflex on the motoneuronal level was dose dependent starting at concentrations of 5 x 10(-3) M octopamine [2].
  • Systemic arterial pressure (SAP) was varied with administration of norfenefrine or by hemorrhage in order to obtain SAP/cerebral blood flow (CBF) curves under different conditions [3].
  • Norfenefrine: haemodynamic effects in healthy volunteers at rest and during orthostasis [4].
 

High impact information on Zondel

 

Chemical compound and disease context of Zondel

 

Biological context of Zondel

 

Anatomical context of Zondel

 

Associations of Zondel with other chemical compounds

 

Analytical, diagnostic and therapeutic context of Zondel

References

  1. Early multiple organ failure after recurrent endotoxemia in the presence of vasoconstrictor-masked hypovolemia. Hinder, F., Stubbe, H.D., Van Aken, H., Baba, H.A., Jahn, U.R., Brodner, G., August, C., Erren, M., Booke, M. Crit. Care Med. (2003) [Pubmed]
  2. Octopamine effects mimick state-dependent changes in a proprioceptive feedback system. Büschges, A., Kittmann, R., Ramirez, J.M. J. Neurobiol. (1993) [Pubmed]
  3. The influence of nimodipine on cerebral blood flow autoregulation and blood-brain barrier. Höllerhage, H.G., Gaab, M.R., Zumkeller, M., Walter, G.F. J. Neurosurg. (1988) [Pubmed]
  4. Norfenefrine: haemodynamic effects in healthy volunteers at rest and during orthostasis. Magometschnigg, D., Stengele, E. Eur. J. Clin. Pharmacol. (1983) [Pubmed]
  5. Effects of denervation of the levels of p-octopamine m-octopamine (norphenylephrine) and phenylethanolamine in rat salivary gland. Robertson, H.A., David, J.C., Danielson, T.J. J. Neurochem. (1977) [Pubmed]
  6. Sympathetic regulation of glucose uptake by the alpha1-adrenoceptor in human obesity. Flechtner-Mors, M., Jenkinson, C.P., Alt, A., Biesalski, H.K., Adler, G., Ditschuneit, H.H. Obes. Res. (2004) [Pubmed]
  7. In vivo alpha(1)-adrenergic lipolytic activity in subcutaneous adipose tissue of obese subjects. Flechtner-Mors, M., Jenkinson, C.P., Alt, A., Adler, G., Ditschuneit, H.H. J. Pharmacol. Exp. Ther. (2002) [Pubmed]
  8. The metabolism of L-m-tyrosine: the use of a putative precursor to investigate the increased production of m-hydroxymandelic acid in phenylketonuria. Hoskins, J.A., Greenway, A.M. Clin. Chim. Acta (1983) [Pubmed]
  9. Norfenefrine in the treatment of female urinary stress incontinence assessed by one-hour pad weighing test. Diernaes, E., Rix, P., Sørensen, T., Alexander, N. Urologia internationalis. (1989) [Pubmed]
  10. In vitro occurrence of m-octopamine in the cultured cephalic ganglion of Locusta migratoria L. after L-dopa administration. Coulon, J.F., Lafon-Cazal, M., David, J.C. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. (1984) [Pubmed]
  11. Ultrastructural changes in the blood-brain barrier after nimodipine treatment and induced hypertension. Zumkeller, M., Höllerhage, H.G., Reale, E., Dietz, H. Exp. Neurol. (1991) [Pubmed]
  12. Heat shock protein 72 and apoptosis indicate cardiac decompensation during early multiple organ failure in sheep. Baba, H.A., Wohlschlaeger, J., Stubbe, H.D., Grabellus, F., Aken, H.V., Schmitz, K.J., Otterbach, F., Schmid, K.W., August, C., Levkau, B., Hinder, F. Intensive care medicine. (2004) [Pubmed]
  13. Bioavailability of m-octopamine in man related to its metabolism. Hengstmann, J.H., Konen, W., Konen, C., Eichelbaum, M., Dengler, H.J. Eur. J. Clin. Pharmacol. (1975) [Pubmed]
  14. Effects of molindone and fluphenazine on the brain concentration of some phenolic and catecholic amines in the mouse and the rat. Juorio, A.V. Br. J. Pharmacol. (1980) [Pubmed]
  15. The effects of m-octopamine on salivary flow rates and protein secretion by rat submandibular glands. Okina, A., Abe, K., Inuzuka, H., Yano, T., Okina, T., Nakashima, T., Nishiura, T. Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. (1992) [Pubmed]
  16. Evidence for neuronal uptake and release of norfenefrine and evaluation of its alpha-agonistic effects in the rabbit pulmonary artery. Reimann, W. Arzneimittel-Forschung. (1984) [Pubmed]
  17. Age variation in the increase of hypothalamic and brain stem contents of phenylethanolamine m-octopamine and p-octopamine in spontaneously hypertensive rats (SH Kyoto). David, J.C. Experientia (1979) [Pubmed]
  18. Cardiovascular effects of amezinium in humans during passive upright tilt in comparison with norfenefrine and dihydroergotamine. Wilsmann, K., Neugebauer, G., Kessel, R., Lang, E. Arzneimittel-Forschung. (1981) [Pubmed]
 
WikiGenes - Universities